Objectives: Many studies have reported that olfactory dysfunction frequently occurs in chronic rhinosinusitis (CRS) populations; however, the prevalence and degree of olfactory loss has not been systematically studied. The aims of this study were to use combined data to report the prevalence of olfactory dysfunction and to calculate weighted averages of olfactory test scores in CRS patients.
INTRODUCTION
Chronic rhinosinusitis (CRS) affects nearly one in eight adults in the United States 1 and is a leading causes of olfactory dysfunction worldwide. 2, 3 Clinicians are increasing focus toward olfactory impairment, a cardinal symptom used to diagnose CRS, due to its direct and indirect effects on behavior, nutritional status, and environmental safety. 4 A recent study even linked smell loss to increased mortality, a finding not seen with hearing or vision loss. 5 Understanding the scope of CRS-related olfactory dysfunction benefits multiple stakeholders, including patients, physicians, researchers, and healthcare policy makers.
Many studies have reported olfactory dysfunction frequently occurs in CRS populations; however, the prevalence and degree of olfactory loss has not been systematically studied. Population-based studies separating olfactory dysfunction by etiology sometimes use imprecise proxies such as sinus infections or nasal congestion, which do not necessarily translate into a formal diagnosis of CRS. 6, 7 In addition, studies exploring olfaction in CRS often use differing test methods, making direct comparisons difficult.
The main objective of this study was to perform a systematic review with meta-analysis and pooled data analysis on of the prevalence and degree of olfactory dysfunction, respectively, in patients with CRS. The secondary aim was to review patient-specific factors that might impact olfaction within CRS, including demographics, CRS-specific disease severity measures, and comorbidities.
METHODS

Literature Search Strategy
A comprehensive literature search of PubMed (January 1947-November 2015) and Scopus (January 1973-November 2015) was conducted on November 29, 2015 . The full search term for PubMed was ("Smell" [Mesh] OR smell* OR "Olfaction Disorders" [Mesh] OR olfact* OR Anosmi* OR "Olfactory Perception" [Mesh] OR Hyposmi* OR "Odors" [Mesh] OR odor*) AND (rhinosinusitis OR sinusitis). The full search term for Scopus was (smell* OR olfact* OR Anosmi* OR Hyposmi* OR odor*) and (rhinosinusitis OR sinusitis). Language and date filters were not applied with the intention of generating a broad list of potential studies. Figure 1 highlights the search strategy used in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 8 Reference lists of all obtained articles were examined for additional studies meeting inclusion criteria. Two authors (P.K. and E.E.H.) independently conducted the database searches. The resulting studies were reviewed first using titles and abstracts and then full articles. Each included study was evaluated for quality using the Oxford Center for Evidence-Based Medicine criteria. 9 
Inclusion/Exclusion Criteria
Patients in each included study must have been diagnosed with CRS using specified diagnostic criteria, such as characteristic symptoms and/or imaging, although this was allowed to vary across individual studies. Included studies had to present data on quantitative olfactory loss using a validated scale or report the prevalence of olfactory dysfunction using an objective testing measure. Articles were excluded if the overall cohort included non-CRS patients that could not be separated. Studies that preferentially enrolled patients with olfactory disturbances were excluded, as were reviews and individual case reports. In instances where multiple studies were clearly published from an overlapping cohort of patients, the largest and/or most recent study was utilized so as not to include duplicate data in weighted estimates.
Data Extraction and Statistical Analysis
Data were extracted from studies meeting inclusion criteria by three authors (P.K., A.N.N., and E.E.H.) using standardized forms. Extracted information included: criteria used to diagnose CRS, demographic information, CRS-specific disease severity metrics, comorbidities, mean and standard deviation (SD) of any reported olfactory measures, and prevalence of olfactory dysfunction. Continuous variables were summarized by the mean 6 standard deviation. Nominal variables were summarized by percentage. A meta-analysis of proportions was performed to combine prevalence estimates. Heterogeneity across studies was assessed using the I 2 statistic. If the heterogeneity test was significant, the P value for a random effects model was used. If the heterogeneity test was nonsignificant, the P value for a fixed effects model was used. The use of a fixed or random effects model is indicated as "fixed" or "random" in the Results section. Means and SDs for combination of olfactory test data were weighted according to study sample sizes. Data are presented first for studies presenting composite measures of objective olfactory function, followed by those that evaluated identification or threshold tests, and lastly those that used alternative measures of olfaction. Ninety-five percent confidence intervals extracted from studies were converted to SDs according to Cochrane guidelines. 10 Independent t tests were used to compare differences between polyp groups. A P value of <.05 was considered statistically significant for all statistical tests. All analyses were performed using MedCal 16.4.3 (MedCalc Software bvba, Ostend, Belgium)
Risk Bias Assessment
Included articles were assessed for bias risk using two domains of the Quality in Prognosis Studies tool that are relevant to prevalence studies: study participation (risk of selection bias) and outcome measurement (risk of outcome bias). 11 Each domain was subjectively evaluated (ranked as low, moderate, or high) and provided in the respective tables (Tables (I-III) ). For risk of selection bias, the major criteria used to evaluate studies included: 1) method of CRS diagnosis (greater bias in studies that did not use established guidelines), 2) type of treatment, if any, the cohort elected (greater bias in studies only providing data on patients electing surgery), and 3) single versus multiinstitutional studies (greater bias in single institution studies). Minor criteria included characteristics such as whether the enrollment process was described, if sampling time frame was described, and if comorbidities between patients with and without olfactory dysfunction were described. For risk of outcome bias, studies that used a validated measure of olfaction and described the testing process and scoring were ranked as low bias studies. Studies using nonvalidated measures of olfaction were ranked as higher levels of bias.
RESULTS
Search Characteristics
The database search yielded 871 citations, of which 231 full articles were reviewed; 47 articles fulfilled inclusion/exclusion criteria (Fig. 1) . Tables I, II, and III Fig. 2 ). Four studies in CRS mixed 12, 14, 16, 17 presented TDI total scores, yielding a population of 253 patients. Pooled TDI score was 21.96 6 8.88, which falls into hyposmic range (Table IV) .
Two studies in chronic rhinosinusitis with nasal polyps (CRSwNP) 18, 19 reported the prevalence of olfactory dysfunction using the total TDI. The combined prevalence of normosmics, hyposmics, anosmics, and overall olfactory dysfunction was 6.32% (I 2 5 96.81%; random), (Table IV) .
CONNECTICUT CHEMOSENSORY CLINICAL RESEARCH CENTER TEST. Two studies in CRS mixed 22, 23 and one study in CRSwNP 24 reported the prevalence of olfactory dysfunction using the Connecticut Chemosensory Clinical Research Center test, which includes both threshold and identification measures. Because enough studies did not provide the raw number of patients, combined prevalence in CRS mixed patients could not be calculated; however, prevalence estimates from individual studies are reported in Table I . The weighted combination of olfactory scores was also unable to be performed due to variations in olfactory testing procedures among studies.
Identification. [25] [26] [27] [28] reported the prevalence of olfactory dysfunction using the 40-Item Smell Identification Test (SIT-40). The combined prevalence of normosmics, hyposmics, anosmics, and overall olfactory dysfunction was 34.39% (I 2 5 0.00%; fixed), 43.96% (I 2 5 0.00%; fixed), 21.90% (I 2 5 0.00%; fixed), and 67.00% (I 2 5 58.46%; fixed), respectively (Table II, Fig. 3 ).
40-ITEM SMELL IDENTIFI-CATION TEST. Four studies in CRS mixed
Olfactory status using the SIT-40 is classified as: 0 to 5 malingering, 6 to 19 anosmic, 20 to 33 hyposmic, and 34 to 40 normosmic. 29 Twelve studies presented SIT-40 scores amenable to combination analysis, yielding a population of 1,576 CRS mixed patients. 26, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] The pooled SIT-40 score was 25.96 6 7.11, which falls in the hyposmic range (Table IV) .
BRIEF SMELL IDENTIFICATION TEST. Three studies in CRS mixed [40] [41] [42] reported the prevalence of olfactory dysfunction using the Brief Smell Identification Test (B-SIT). Normosmia using the B-SIT is classified as a score 9 normosmia. 41 The combined prevalence of olfactory dysfunction was 29.97% (I 2 5 91.12%; random) (Table II) .
Three studies presented B-SIT scores amenable to combination analysis, yielding a population of 520 CRS mixed patients. 40, 42, 43 The pooled B-SIT score was 8.60 6 2.81, which falls into the abnormal olfactory range (Table IV) . SNIFFIN' STICKS. Six studies in CRS mixed 12, 14, 16, [44] [45] [46] and two studies in CRSwNP 18, 19 presented standard 16-odor identification scores, yielding a population of 899 and 187 patients, respectively. Olfactory dysfunction using the 16-odor Sniffin' Sticks identification test is defined as scores 11.
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Pooled identification scores were significantly higher in CRS mixed patients when compared to CRSwNP (9.47 6 3.92 vs. 6.04 6 3.14, P < .0001), although both were abnormal (Table IV) .
Three studies in CRS mixed [47] [48] [49] and two studies in chronic rhinosinusitis without nasal polyps 50, 51 presented modified 12-odor identification scores, yielding a population of 245 and 53 patients, respectively. Olfaction is classified using the 12-odor Sniffin' Sticks identification test as: 0 to 6 anosmic, 7 to 10 hyposmic, and 11 to 12 normosmic. 52 Pooled identification scores were nonsignificantly higher in CRS mixed patients when compared to CRSsNP (8.06 6 3.06 vs. 7.25 vs. 1.52, P 5 .0617), although both were in hyposmic range (Table IV) .
Threshold. SNIFFIN' STICKS-THRESH-OLD. Six studies in CRS mixed 12, 14, 16, [53] [54] [55] and two studies in CRSwNP 18, 19 presented threshold scores, yielding a population of 386 and 187 patients, respectively. Olfactory dysfunction using the Sniffin' Sticks threshold tests is defined as 6.00 in males and 6.50 in females. Pooled threshold scores were significantly higher in CRS mixed patients when compared to CRSwNP (5.65 6 1.51 vs. 2.28 6 2.11, P < .0001), although both were abnormal (Table IV) . BUTANOL THRESHOLD TEST. Three studies in CRS mixed 44, 56, 57 reported the prevalence of olfactory dysfunction using the Butanol Threshold Test (BTT) ( Table III OTHER THRESHOLD TESTS. One study of 28 CRS mixed patients reported the prevalence of hyposmia using the Phenylethyl Alcohol test as 42.9%. 58 One study of 25 CRS mixed patients reported the prevalence of anosmia using the Olfactometer Threshold Test as 32%. 59 One study of 115 CRS mixed patients reported the prevalence of normosmia, hyposmia, and anosmia as 16%, 52%, and 31%, respectively, using a nonvalidated threshold test 60 (Table III  Alternative measures of olfaction. SNIF-FIN' STICKS-DISCRIMINATION. Three studies in CRS mixed 12, 14, 16 and two studies in CRSwNP 18,19 presented discrimination scores, yielding a population of 189 and 187 patients, respectively. Olfactory dysfunction using the Sniffin' Sticks-Discrimination is defined as 10.
Pooled discrimination scores were significantly higher in CRS mixed patients when compared to CRSwNP (9.21 6 4.63 vs. 6.48 6 3.46, P < .0001), although both were abnormal (Table I) .
EUROPEAN TEST OF OLFACTORY CAPABILI-TIES. One study of 30 CRSwNP patients reported the prevalence of normosmia, hyposmia, and anosmia as 6.7%, 30.0%, and 63.3%, respectively, using the European Test of Olfactory Capabilities 61 (Table III) . QUESTIONNAIRE OF OLFACTORY DISORDERS-NEGATIVE STATEMENTS. Two studies in CRS mixed patients presented the Questionnaire of Olfactory Disorders-Negative Statements (QOD-NS) scores in 213 patients.
12,13 QOD-NS scores range from 0 (poor smell) to 51 (normal smell). 62 The pooled QOD-NS score was 8.90 6 5.14 (Table IV) . 
Factors Associated With Olfactory Dysfunction
Given the high prevalence of olfactory dysfunction in CRS, we examined included studies for factors that may help clinicians identify patients at highest risk of smell loss. Twenty-three of the 47 included studies reported predictors. Among demographic factors, higher age was most frequently associated with poorer smell, with seven studies reporting this association. 12, 19, 27, 40, 46, 48, 63 Two studies did not find any association between age and olfactory dysfunction. 57, 64 Within CRS-specific factors, a higher Lund-Mackay (LM) computed tomography (CT) score was most frequently associated with poorer smell with 11 studies reporting this relationship. 18, 21, 27, 38, 40, 50, 51, 53, 57, 61, 64 Remaining studies did not examine this association. Among comorbid factors impacting smell, nasal polyposis was most frequently associated with olfactory dysfunction, with 10 studies reporting an association. 12, 22, 27, 32, 40, 46, 51, 60, 62, 64 Remaining studies did not examine this relationship.
DISCUSSION
This study systematically reviewed olfactory impairment in CRS and estimated the prevalence of olfactory dysfunction in CRS to be 29.97% using the B-SIT, 67.00% using the SIT-40, and 78.23% using total TDI score. Weighted means of each composite and individual olfactory measure fell into the range for olfactory dysfunction, further confirming its high prevalence in CRS populations. Additionally, the pooled QOD-NS score of 8.90 suggests that smell loss significantly impacts the quality of life of CRS patients including social, physical, and emotional well-being.
Given these findings, we reviewed studies for factors associated with olfactory dysfunction. Higher LM CT scores were most frequently associated with poorer smell. Inflammatory changes apparent on CT scans are caused by nasal discharge, edema, or polyps, which restrict the flow of odorant-permeated air in the nasal passages. 65 Inflammation can also produce structural changes to the pseudostratified columnar epithelium, which contains bipolar neurons, disrupting the propagation of signals to the olfactory bulb and primary sensory cortex. 65 Nasal polyposis was the most frequently associated comorbidity in patients with olfactory dysfunction. Nasal polyps are physical barriers to odorants, and the ongoing inflammation associated with this subgroup could contribute to permanent neuroepithelial damage. Higher age was the most frequent demographic factor to be associated with poorer smell and is previously well studied. 7, 66, 67 The prevalence of olfactory impairment is subgroup and test dependent. CRSwNP groups experienced higher levels of olfactory dysfunction than CRS mixed populations. Although prevalence estimates using TDI and the SIT-40 were comparable, the B-SIT led to a much lower value. Even though the B-SIT may be more clinically feasible, it likely underestimates true olfactory dysfunction in CRS populations. Prior studies by Alt et al. and Deconde et al. agree that the B-SIT lacks sensitivity in classifying degree of identification loss. 40, 41 The combination analysis of olfactory scores (Table IV) , in which the B-SIT came closest to the normosmic cutoff out of all the composite olfactory measures, supports this hypothesis. Given the goal of testing to maximize sensitivity, when possible, Sniffin' Sticks and the SIT-40 are the preferred methods of olfactory measurement.
The prevalence of olfactory dysfunction using the total TDI score was slightly higher than the SIT-40. This difference may be because the Sniffin' Sticks tests all three components of olfaction, whereas the SIT-40 tests only identification. In Table IV , we found CRS-related olfactory dysfunction to impact each subcomponent of TDI, highlighting that a comprehensive olfactory assessment may have greater ability to detect olfactory impairment than any single component. L€ otsch et al. conducted a study in idiopathic Parkinson's disease patients using Sniffin' Sticks and found test sensitivity to increase as more subcomponents were used. 68 The mechanism and degree to which each of these subcomponents is affected in CRS remains unknown and is an area of further study. However, it is possible that relying solely on identification may underestimate the prevalence of olfactory dysfunction.
Strengths of this study include its systematic design, broad coverage of testing methodologies, and relatively large sample sizes for the most common metrics. As with all reviews, the study was restricted to available data, which limited some conclusions. This was particularly true for the CRSsNP population, which was not reported as a separate and distinct subgroup in most studies. There is also inherent selection and/or publication bias, because most patients enrolled in studies were seeking treatment for CRS. Although representative of patients presenting for clinical care, it may not be generalizable to all patients with CRS, particularly those with milder and less symptomatic disease. Although an effort was made to minimize redundancy by using only the largest or most recent studies from cohort studies, it remains possible that some studies overlapped in terms of the included patients.
CONCLUSION
A significant percentage of CRS patients experience olfactory dysfunction and mean olfactory scores of CRS cohorts are well within the dysosmic range. Age, inflammatory changes on CT, and nasal polyps are the most common factors associated with olfactory dysfunction across studies. Fig. 3 . Meta-analysis of prevalence of olfactory dysfunction using 40-item Smell Identification Test. [Color figure can be viewed in the online issue, which is available at www.laryngoscope.com.]
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